GlassScriptPhysician profile
Tyson C Cobb
NPI 1710982061
$7,324.96
in general payments reported to CMS, 2019-2025
39 companies · $599 in 2025
The $599 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,814 · 2020: $847 · 2021: $1,468 · 2022: $1,247 · 2023: $765 · 2024: $586 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,949.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,355.66 | 2019-2025 | |
| Amgen INC. | $626.84 | 2019-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $596.83 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $547.70 | 2020-2024 | Jardiance |
| Pfizer INC. | $510.09 | 2019-2025 | |
| Abiomed | $415.46 | 2021 | |
| Abbott Laboratories | $393.96 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $300.56 | 2019-2024 | Xarelto |
| Cardiovascular Systems INC. | $234.52 | 2019-2021 | |
| Astellas Pharma US INC | $226.53 | 2021-2022 | |
| Shockwave Medical, INC | $191.02 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kestra Medical Technology Services, INC. | $185.29 | 2022-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $169.65 | 2022-2024 | Lifevest |
| Kowa Pharmaceuticals America, INC. | $144.38 | 2019-2022 | |
| Biotronik INC. | $140.93 | 2019 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyson Cobb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.